The prognostic impact of KRAS mutation was recently analyzed in a large pool of colon cancer patient wild-types for the BRAF gene (to exclude from the analysis patients with mutated BRAF, who have a poor prognosis). The gene discussed is KRAS; the disease is colonic neoplasm.